Next Article in Journal
Small Molecule B-RAF Inhibitors as Anti-Cancer Therapeutics: Advances in Discovery, Development, and Mechanistic Insights
Next Article in Special Issue
Carvacrol Protects IPEC-J2 Cells from Oxidative Stress by Suppressing Autophagy
Previous Article in Journal
Developmental Endothelial Locus-1 Promotes Osteoclast Differentiation and Activation
Previous Article in Special Issue
Biological Activities and Phytochemical Screening of Thuja occidentalis Extracts with In Silico Approaches
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Review

Contributions of Dietary Patterns and Factors to Regulation of Rheumatoid Disease

by
Jingjie Zhang
1,2,3,
Xueli Wang
1,2,3,
Juan Fang
1,2,3,
Yingying Li
1,2,3,
Yonghui Yu
1,2,3,*,
Jing Wang
1,2,3,* and
Baoguo Sun
1,2,3
1
Key Laboratory of Geriatric Nutrition and Health, Ministry of Education, Beijing Technology and Business University, Beijing 100048, China
2
China-Canada Joint Laboratory of Food Nutrition and Health, Beijing Technology and Business University, Beijing 100048, China
3
Key Laboratory of Special Food Supervision Technology for State Market Regulation, Beijing Technology and Business University, Beijing 100048, China
*
Authors to whom correspondence should be addressed.
Int. J. Mol. Sci. 2025, 26(6), 2674; https://doi.org/10.3390/ijms26062674
Submission received: 31 December 2024 / Revised: 4 March 2025 / Accepted: 13 March 2025 / Published: 16 March 2025
(This article belongs to the Special Issue Antioxidant and Antibacterial Properties of Phytochemicals)

Abstract

:
Rheumatoid arthritis (RA) is a systemic autoimmune disease that commonly causes pain in joints and the progressive destruction of cartilage and bone, which significantly reduces the quality of life and increases the social burden. However, there is still no cure for RA, so it is highly important to explore additional adjuvant treatment methods. Studies have indicated that malnutrition, changes in intestinal microbiota, and changes in immune status caused by dietary imbalance are directly related to the onset of RA, indicating that dietary intervention may offer a simple, economical, and practical avenue to relieve RA. Therefore, in this review, we discuss the pathogenesis of RA and summarize the influence of different dietary patterns on RA. In particular, we pointed out that high-fat, high-sugar, and high-salt diets contribute to RA progression, whereas the Mediterranean diet (MD) is beneficial for preventing RA. Furthermore, the ingredients of food, such as dietary fiber, probiotics, and vitamins, help reduce the level of inflammation and relieve joint pain, which may play critical roles in the treatment of RA. Therefore, dietary intervention provides a potential effective approach for adjuvant therapy of RA.

1. Introduction

RA is a chronic systemic autoimmune disease, characterized by painful and swollen joints, leading to irreversible joint deformity, which can significantly impair physical function [1]. RA was first considered a chronic disorder that causes synovial inflammation and proliferation, autoantibody production, and destruction of cartilage and bone [2]; however, further studies have shown that RA can also impair a wide variety of body systems, such as the lung, kidney, liver, and even cardiovascular systems [3], both of which severely reduce quality of life [4]. Although the prevalence of RA varies globally, the number of RA patients worldwide has been rising annually. From 1990 to 2017, the global age-standardized RA incidence rate increases by 7.4% [5]. The situation is similar in China, where the incidence rate of RA has reached 0.42% on the basis of the latest statistical data [5,6]. According to the predicted population changes, it is estimated that there will be 31.7 million patients with RA worldwide in 2050, which will increase the number of cases by 80.2% from 2020 to 2050 [6], severely increasing the social and medical burden.
Numerous studies have shown that genetics, the environment, immunity, and other factors play key roles in the pathogenesis of RA [7] (Figure 1). Genetic factors are mainly divided into human leucocyte antigen (HLA) genes and other genes, and some alleles of the HLA genes are closely related to the susceptibility to RA [8]. For example, the HLA-DRB1 gene, such as HLA-DRB1*0401, HLA-DRB1*0404, and HLA-DRB1*0101, has been shown to be the genetic factor with the strongest correlation with RA [9]. These genes may change the process of antigen presentation, and the immune system will wrongly recognize and attack joint tissues [10]. In addition, polymorphisms in PTPN22, CTLA-4, and other genes have also been considered to be associated with RA [11]. Therefore, although RA is not directly heritable, genetics and family history have been found to be relevant to the increasing risk of RA [12].
However, genetic predisposition accounts for only 30–60% of the risk of RA, whereas 40–70% of RA risk is influenced by non-genetic factors [13]. As shown in Figure 1, the onset age of RA is usually between 30 and 50 years, reaching its peak between 50 and 75 years, and approximately 75% of patients are women [14], indicating that age and sex also have a significant effect on the risk of RA. Non-genetic factors, including the following aspects, have an important influence on the onset of RA [15]: (1) Infection: Microbial infection is thought to play an important role in the occurrence and persistence of RA. The results of clinical trials and animal model studies have shown that multiple microbial infections, including Porphyromonas gingivalis [16], Proteus mirabilis [17], Epstein–Barr virus [18], and mycoplasma [19], may cause the onset of RA in susceptible individuals. (2) Chemical exposure: Long-term exposure to certain chemical substances (such as silica dust, organic solvents, and chemical components in tobacco, etc.) may increase the risk of RA [20]. (3) Underlying diseases: There is a close relationship between cardiovascular disease and RA. Research shows that patients with RA are at increased risk of cardiovascular disease [21], which has been at least partially attributed to elevated levels of inflammatory factors in the body. Research has confirmed this relationship from another perspective, that C-reactive protein (CRP) has shown an increasing trend in both of these diseases [22]. In addition, obesity is considered an important factor leading to an increase in systemic inflammatory levels and further increases the incidence and severity of RA [23]. Specifically, excessive body mass index may have negative impacts on patients with RA, including increased disease risk and disease activity index, reduced quality of life, and insensitivity to treatment [24]. (4) Lifestyle: A lifestyle of nonsmoking, healthy eating, and moderate exercise can increase the body’s antioxidant capacity [25], reduce inflammation [26], regulate immunity [27], improve joint function, and relieve pain [28], thereby lowering the incidence of RA. In contrast, lifestyle factors such as unhealthy diets, a lack of exercise, and/or smoking contribute to aggravated inflammation [29,30], reduced muscle mass [31], and increased joint stiffness [32], all of which may worsen symptoms of RA or increase the risk of developing RA. (5) Stress: Stress can not only affect the function of the immune system but also lead to an increase in the inflammatory response, thus aggravating the symptoms of rheumatoid arthritis. Stress can also trigger changes in hormone levels in the body, such as cortisol secretion, which may affect the body’s inflammatory response. (6) Other factors: Citrullination, a type of posttranslational modification, converts arginine to citrulline in certain proteins. Abnormal citrullination might disrupt the natural self-immune tolerance. Citrullinated proteins can be recognized as foreign antigens and trigger an immune response to produce anti-citrullinated autoantibodies, resulting in RA [32]. In addition, sex differences in immune responses are also important factors in triggering RA. This is why the incidence of RA in women is significantly greater than that in men [33].
Among these non-genetic factors, dietary factors, in particular, have been found to play critical roles in RA progression (Figure 1). Healthy dietary patterns, such as the Mediterranean diet (MD), which is rich in plant foods, whole grains, healthy fats, and fish, have been proven to be beneficial for reducing the risk of RA [34], whereas unhealthy dietary patterns, including high-sugar and high-fat diets, have been found to promote RA progression [35]. The fact that the impact of different dietary patterns on RA varies greatly is largely attributed to differences in the types and amounts of nutrients they contain [36]. The content and proportion of nutrients play important roles in the occurrence and severity of diseases. Studies have shown that some dietary choices may have pro-inflammatory or anti-inflammatory effects, thus affecting the immune system function in vivo [37].
Further studies have shown that some ingredients enriched in healthy diets have significant effects on reducing inflammatory levels in the body, which may contribute to the management of RA. For example, omega-3 fatty acids possess functions of immunomodulatory properties, anti-inflammatory reaction, and balancing gut microbiota and have been proven to be effective in relieving RA symptoms [38,39,40]. Clinical studies indicated that consumption of omega-3 fatty acids could significantly improve eight RA-related markers [41]. Vitamins and minerals are also essential for the normal function of the immune system. Deficiencies in vitamins D, C, and zinc may lead to immune system disorders, thus increasing the risk of RA [42]. As an antioxidant, vitamin E helps reduce oxidative stress and thus reduces the probability of RA [43]. Dietary fiber is another nutrient that is considered beneficial for RA management. On the one hand, dietary fiber can directly reduce systemic inflammation by enhancing intestinal barrier function [44]. On the other hand, dietary fiber contributes to improving the intestinal microbiota, and its metabolites, such as short-chain fatty acids, can regulate metabolism and immune status (promotion of regulatory T cells), thus indirectly alleviating RA [45]. Therefore, it is important to pay attention to diet structure and composition, especially for the management and prevention of RA. In this review, we summarize the influence of different patterns on RA progression and analyze the effects of nutrients enriched in healthy diets on relieving RA to provide a potential effective approach for adjuvant therapy of RA.

2. The Pathogenesis of RA

Although the pathogenesis of RA is not fully understood, it is generally believed that the development of RA includes the following stages (Figure 2): (1) The immune system mistakenly identifies self-tissues as heterologous substances, which leads to the activation of the immune response and the persistence of inflammation [46]. (2) Large amounts of cytokines are secreted and released, followed by increased immune cell and cytokine levels, especially in the joint tissue, which further promotes the inflammatory reaction [47]. (3) Inflammation leads to synovial cell proliferation and migration, leading to synovitis unique to RA [48], followed by the release of proangiogenic factors, such as vascular endothelia growth factor (VEGF) and basic fibroblast growth factor (bFGF), to promote angiogenesis [49]. In addition, inflammatory factors further increase vascular permeability, resulting in joint swelling [47]. (4) Continuous inflammatory reactions lead to the degradation of articular cartilage and bone destruction [50]. Large amounts of cytokines, such as interleukin-1β (IL-1β) and tumor necrosis factor-α (TNF-α), which are released by immune and synovial cells, promote the secretion of metalloproteinases (MMPs) [51]. MMPs can subsequently degrade cartilage matrix components, such as collagen fibers and proteoglycans, resulting in destructive damage to cartilage [52]. These inflammatory factors also directly stimulate the differentiation and activation of osteoclasts and promote bone resorption [53]. The destruction of cartilage and bone further stimulates synovial cells to secrete more inflammatory factors, forming a vicious cycle [54]. Therefore, inflammation serves as a critical stage in the pathogenesis of RA, and the inhibition of inflammation is considered a potentially effective way to relieve RA.

3. Effects of Different Dietary Patterns on RA Progress

The types and quantities of foods that people consume vary with region, habits, and personal preferences [55], and there are also significant differences in nutrient composition among these patterns [56]. Dietary patterns can be divided into balanced dietary patterns and unbalanced dietary patterns on the basis of whether they contribute to keeping us healthy, both physically and mentally [57]. The balanced diet pattern usually contains a variety of foods, which can provide enough macro- and micro-nutrients to meet the nutritional needs of the body [58], whereas the unbalanced dietary pattern lacks some nutrients, leading to malnutrition or related health problems [59]. As shown in Table 1, studies have shown that dietary patterns have a potentially important influence on the occurrence and development of RA [60].

3.1. Unbalanced Diet Patterns

3.1.1. High-Fat Diet

A high-fat diet refers to a diet consisting of at least 35% of the total calories consumed from fats, including both unsaturated and saturated fats [73]. This diet pattern mainly contains foods enriched with animal fat (such as red meat, pork, full-fat dairy products, and poultry) and those rich in plant fat (such as vegetable oil, nuts, and seeds) [74], which usually results in high energy density. Common processing methods, such as frying, even increase the fat content.
The long-term consumption of high-fat diets not only leads to elevated blood lipids and obesity but also may result in a range of health complications, such as cardiovascular disease, metabolic syndrome, or gastrointestinal issues [61,62]. A previous study revealed that excess dietary intake disturbs the “clock” of the body, leading to metabolic disorders such as diabetes and obesity [75]. High-fat food is also considered one of the key factors of obesity and is often accompanied by a series of chronic inflammatory diseases, such as type II diabetes mellitus and cardiovascular diseases [76]. In addition, a high-fat diet contributes to low-grade chronic inflammation, endocrine dyscrasia, and metabolic disorders by damaging the integrity of the intestinal barrier and lowering microbial diversity, subsequently resulting in an imbalance of the immune system, which has been listed as one of the risk factors for RA (Figure 3). The result of clinical trial has shown that the symptoms of RA in patients with a high-fat diet is significantly more serious than those with an ordinary diet [77], and drugs against TNF-α are less effective in treating obese patients with RA [78], indicating the harmful effects of a high-fat diet on our health.
The effects of a high-fat diet on the risk of RA are multifaceted. First, excess fat intake increases the levels of pro-inflammatory factors, leading to an in vivo inflammatory environment. In a study with a collagen-induced RA animal model, mice fed a high-fat diet had significantly greater arthritis severity scores and a higher incidence of arthritis than C57BL/6 mice in control group at all time points and exhibited synovial pannus formation and progressive joint destruction [79]. Further results showed that the serum level of anti-IgG was elevated, and both the Th17 cell number and the mRNA level of IL-17 in spleen cells were increased [79], suggesting that a high-fat diet may accelerate the inflammatory process and aggravate the symptoms of RA. Another study showed that a high-fat diet accelerated collagen-induced joint inflammation and RA occurrence in mice compared with a normal diet [80]. Subsequent results indicated that a high-fat diet stimulated the migration of neutrophils and led to the early onset of collagen-induced RA [80], suggesting that a high-fat diet may increase the infiltration of joint monocytes and accelerate the process of collagen-induced arthritis.
Other studies had shown that an increase in serum cholesterol is also related to the risk of RA. In particular, higher total cholesterol in women is positively correlated with increased long-term RA risk, which does not exist in men [81]. This trend showed that as a risk factor for RA occurrence, a high-fat diet may be more sensitive in women than in men [82]. In addition, sex-specific exposure alters the metabolism of lipids, and hormone-related metabolic pathways may also influence the occurrence of RA [81]. Taken together, a high-fat diet might promote the inflammatory reaction and further increase the risk of RA.

3.1.2. High-Sugar Diet

Sugars include the sum of all the mono- and di-saccharides, such as glucose, fructose, and sucrose, and a high-sugar diet mainly refers to the daily intake of sugar exceeding 10% of the total energy [83,84]. High-sugar diets can be further divided into high-glucose diets and high-fructose diets [83]. According to the recommendation of the American Diabetes Association, the daily sugar intake of adults should be controlled between 25 g and 36 g [85]. The main sources of a high-sugar diet include sugary foods and drinks, such as candy, cakes, ice cream, and sugary soda water [86]. These foods have high sugar and calories content but low nutritional density and lack of dietary fiber, vitamins, and minerals [87]. Many studies have confirmed that long-term intake of a high-sugar diet may lead to metabolic diseases, such as obesity [88], insulin resistance [86], and fatty liver [89], and further increase the risk of cardiovascular disease and diabetes mellitus [90].
A high-sugar diet also contributes to an increased risk of RA. Clinical trials have shown that drinking sugary soda for a long period of time and the risk of RA onset are positively correlated, especially among women with a family history or other risk factors [91]. Animal studies had shown similar results that high-sugar diet intake induced more severe arthritis symptoms, including obvious joint swelling and tissue damage in a collagen-induced mouse model in comparison to those in a control group [63]. Further study found that high glucose intake increased blood sugar and insulin levels, activated inflammatory cytokines and chemokines, and thus aggravated the inflammatory reaction in individuals with RA [92]. A high-sugar diet led to significant inflammation and cell infiltration of the synovium, suggesting that sugar intake aggravated the inflammatory reaction in a collagen-induced mice model [63]. Other animal experiments also revealed that a high-sugar diet increased the levels of the inflammatory factors TNF-α and IL-6 in mice with RA, thus promoting the formation of osteolytic cells [64]. In addition, a high-sugar diet affects RA via various other pathways. A high-sugar diet increases the accumulation of advanced glycation end products (AGEs), damages articular chondrocytes, and accelerates joint degeneration [93]. Furthermore, a high-sugar diet may reduce bone density, increase the risk of osteoporosis, and affect the stability of joints [94]. Moreover, a high-sugar diet leads to weight gain and increased joint load and may result in aggravated arthritis symptoms [95].

3.1.3. High-Salt Diet

Sodium is the main component of edible salt, and it plays an essential role in the physiological function of mammals by maintaining the volume of extracellular fluid and the generation of cell membrane potential [96]. However, salt consumption may serve as an environmental risk factor for the development of autoimmune diseases. Moderate salt intake is necessary to maintain normal physiological function [97]. Excessive salt intake is associated with the risk of various non-communicable diseases, including hypertension, cardiovascular diseases, and stroke, which eventually leads to increased all-cause mortality [98].
A high-salt diet is also closely related to RA. A cross-sectional and case–control analysis of 18,555 people (including 392 patients with RA) revealed the relationship between dietary salt intake and RA. The median daily total sodium intake was 3.47 g, and the sodium intake increased the risk of RA in a dose-dependent manner [99]. Another nested case–control study was performed, and the results indicated that sodium intake significantly increased the risk of RA among smokers and even more than doubled the risk of RA for smokers [100]. The above studies indicated that a high-salt diet aggravated the risk of RA, and according to further studies, this effect of salt had generally been attributed to the activation of the inflammatory response. Recent studies had shown that increased sodium chloride intake contributes to the activation of pro-inflammatory macrophages (M1) and Th17 cells, significantly enhancing Th17 response, and reducing the number of T regulatory cells, which may increase the risk of RA [65]. In addition, a high-salt diet led to high salt concentration and hypertonicity, which directly activated serum glucocorticoid kinase (SGK1), thus affecting the sodium sensitivity and initial activation of Th17 cells, which might also contribute to RA development [66].

3.2. Balanced Diet Patterns

The balanced diet mode refers to a kind of diet that contains a variety of foods and aims to provide enough nutrients needed by the human body. This pattern emphasizes the diversity of foods and proper nutrient ratios to promote health and prevent chronic diseases [101]. The Mediterranean diet [102], the Dietary Approaches to Stop Hypertension (DASH) diet [103], and the vegetarian diet [104] are considered typical examples of balanced diets, among which the MD has generally been considered the healthiest diet for improving health and delaying aging.
The MD is a diet pattern based on the traditional diet mode in the Mediterranean area [105]. Its core characteristics include a high intake of vegetables, fruits, whole grains, nuts, olive oil, and beans [106]; a moderate intake of fish and poultry; and a low intake of dairy products, red meat, and sweets [107]. In addition, moderate consumption of red wine and seasoning intake of herbs and spices are encouraged [108]. This dietary pattern is rich in polyphenols, plant protein, healthy fat, and dietary fiber, which have multi-dimensional benefits for human health [109], including reducing the level of low-grade inflammation [38], improving cardiovascular health, lowering the risk of metabolic syndrome and diabetes [110], supporting cognitive function, and prolonging health.
(1)
Anti-inflammatory effect: The MD is rich in antioxidants and anti-inflammatory components, such as polyphenols and omega-3 fatty acids, which can reduce the level of systemic inflammation [38,40]. In addition, the MD improved the symptoms of RA and lowered the level of inflammation. Studies have shown that the levels of inflammatory markers (such as CRP and IL-6) in the blood of RA patients with MD are reduced [111].
(2)
Lipid profile improvement: Healthy fats in the MD (such as olive oil and fish oil) can improve the lipid profile by reducing the level of low-density lipoprotein (LDL) and increasing the level of high-density lipoprotein (HDL), thus lowering the risk of cardiovascular diseases and indirectly improving the health status of patients with RA [102].
(3)
Immunoregulation: Some ingredients in the MD (such as prebiotics and probiotics) help to maintain gut microbiota balance and subsequently regulate immune system function, which may relieve the symptoms of RA [112]. The literature has shown that an imbalance in the gut microbiota is closely related to the occurrence of RA [113]. This imbalance may lead to abnormal reactions of the immune system, thus promoting inflammation. The prospect of probiotics as a potential intervention method is emphasized, and it is believed that by restoring the balance of the intestinal microflora, intestinal permeability could be improved, thus alleviating the symptoms of RA and regulating the immune response [113].
(4)
Weight management: The MD is usually low in calories and high in fiber, which helps maintain a healthy weight and relieves the symptoms of RA [114].
(5)
Intestinal health promotion: The MD is usually associated with an increase in intestinal microbial diversity. The Mediterranean diet is rich in fiber, which helps promote intestinal health and improve the diversity of the intestinal microflora, which may be related to the regulation of inflammatory reactions [115].

3.3. Mitigating Factors

Compared with an unbalanced diet, the MD is rich in whole grains, fruits, vegetables, and fermented foods (such as yogurt) [116], and it serves as an important source of dietary fiber, vitamins, and cellulose [117], which contributes to improved intestinal microbiota, enhanced immune system, and reduced inflammation [118] and may have a positive impact on RA patients.

3.3.1. Dietary Fiber

Dietary fiber, which is widely found in foods such as vegetables, fruits, and whole grains, has been recognized as a very important functional food raw material and is called the seventh nutrient. Dietary fiber is usually divided into two types according to whether it is soluble in water: soluble dietary fiber (SDF) and insoluble dietary fiber (IDF). IDF has important swelling properties, whereas soluble fiber is fermented by some gut microbial flora to produce physiologically active metabolites.
Dietary fiber has been proven to be associated with various health benefits: (1) Altering the gut microbiota: Dietary fiber significantly enhances the diversity of intestinal microbiota, increases the relative abundance of beneficial bacteria, such as Bifidobacterium and Lactobacillus, and decreases the relative abundance of harmful bacteria, such as Gram-negative bacteria [119]. (2) Improving the intestinal barrier function: Dietary fiber stimulates intestinal epithelial cells to release mucus and forms a protective barrier resulting in improved natural defenses in the gut. In addition, dietary fiber also helps maintain the tight junction integrity of intestinal epithelial cells, resulting in reduced intestinal permeability and further contributing to an improved intestinal barrier [120]. (3) Production of beneficial metabolites: Secondary metabolites from beneficial bacteria in the gut, such as short-chain fatty acids (SCFAs), which can be significantly induced with the consumption of dietary fiber, provide various health benefits to the host, including regulating the immune system. SCFA is also closely related to the host’s metabolic activity, which plays a critical role in regulating blood sugar level, lipid metabolism, and energy balance [121]. (4) Weight management: Studies have shown that a high-fiber diet markedly increases satiety and decreased total calorie intake, thus contributing to improved weight management and a reduced risk of obesity [87].
Dietary fiber contributes to inhibiting the occurrence and development of RA. On the basis of data from the National Health and Nutrition Examination Survey (NHANES) from 2010 to 2020, high dietary fiber intake was closely associated with a significant reduction in the incidence of RA [44]. This effect of dietary fiber on RA could be at least partially attributed to the regulation of the immune system and inflammation. The results of another trial revealed that the number of circulating regulatory T cells significantly increased, the levels of markers of bone erosion dramatically decreased. And the prognosis of RA patients also improved in RA patients treated with high-fiber diets compared with those in the control group [67]. Further research showed that the increased levels of beneficial bacteria and their metabolite SCFAs were involved in this process. Arthritic mice that consumed resistant starch presented significant relief of arthritis symptoms, including swelling and pain, accompanied by an increased abundance of some beneficial bacteria and the production of propionic acid [68]. The results of a clinical trial with RA patients also revealed that an increase in dietary fiber led to a significant increase in systemic SCFA levels, especially the concentrations of acetic acid, propionic acid and butyric acid, and the level of inflammatory markers decreased significantly, indicating that the inflammatory response was alleviated [122]. Further study proved the role of SCFAs in the management of RA, as the severity of arthritis dramatically decreased and the development of RA was inhibited in mice with RA injected with butyric acid (a SCFA that can be produced by microbial decomposition of dietary fiber) [123]. The mechanism of this study involves butyric acid increasing the level of 5-hydroxyindole-3-acetic acid, activating aromatic hydrocarbon receptors, and altering the direction of B cell differentiation, thus alleviating arthritis and inhibiting the development of RA [123]. These studies indicate that their condition may be improved by adjusting their diet and provide a potential non-drug intervention strategy for arthritis patients.

3.3.2. Probiotics

Probiotics are living microorganisms, such as lactic acid bacteria (Lactococcus lactis, Lactobacillus acidophilus), bifidobacteria, and yeast [124], that mainly colonize the human intestines and provide health benefits [125]. Fermented foods, including yogurt and kimchi, are the main source of probiotics in the diet. They are usually classified as “functional microbes” because they play massive roles in maintaining health [126]. The intake of probiotics helps to change the composition of the gut microbiota by both increasing the relative abundance of beneficial bacteria and suppressing the colonization and growth of pathogenic bacteria, which not only contributes to improved intestinal barrier function and reduces the occurrence of diarrhea and constipation but also promotes the absorption of nutrients such as vitamin K and regulates metabolism [127,128,129]. Recent studies have revealed that there is a connection between the intestine and the brain. Probiotics may improve mental states, such as anxiety and depression, by affecting the gut microbiota [130]. Moreover, probiotics also have certain beneficial effects on the immune system by promoting the activity of immune cells and secreting antibodies, thus improving resistance to infection [131]. Probiotics have a positive effect on relieving chronic inflammatory diseases, such as obesity [132].
As shown in Table 2, probiotics have shown significant mitigation effects on the development of RA. In a randomized, double-blind and placebo-controlled clinical trial, the levels of pro-inflammatory cytokines (such as TNF-α and IL-6) were significantly reduced in patients with Lactobacillus casei supplementation, and the clinical symptoms (such as joint swelling and pain) of patients also improved compared with those in the control group, indicating that probiotics may improve the symptoms of RA by adjusting the composition of the intestinal flora, enhancing the immune function, and reducing systemic inflammatory response [69,133]. Animal studies revealed similar results: a rat model of RA induced by Freund’s adjuvant (AIA) with continuous administration of different effective doses of probiotics resulted in less pain and significantly decreased levels of cytokines, and the infiltration of inflammatory cells decreased [70,134,135]. These results suggest that probiotics may be used as effective adjuvant therapies for the management of inflammatory joint diseases.

3.3.3. Vitamins

Vitamins are essential nutrients needed by the human body and are widely present in foods, especially whole grains, nuts, green leafy vegetables, meat, and dairy products. Vitamin D is very important for the metabolism of calcium and phosphorus, which contributes to the health of bones, whereas vitamin D deficiency may lead to osteoporosis or rickets [136]. In addition, vitamin D assists in regulating the immune system and reducing inflammatory reactions. In vitro studies have shown that the active form of vitamin D [1,25-dihydroxyvitamin D, 1,25(OH)2D] has strong anti-proliferative, antibacterial, and anti-inflammatory properties [137].
It has widely been reported that a vitamin D deficiency is very common in patients with RA [138], and the level of serum vitamin D is negatively correlated with the incidence and disease activity of RA [139]. Thus, the level of serum 25-hydroxyvitamin D could be used as an index to evaluate the severity of RA. Furthermore, vitamin D supplementation significantly relieves joint pain, swelling, and dysfunction, and the levels of inflammatory markers such as CRP and TNF-α are obviously decreased [71]. These results indicate that vitamin D supplementation may be related to improvements of patients’ quality of life, especially in physical function and pain management.
Vitamin K plays an important role in blood coagulation and bone health, and a lack of vitamin K may lead to bleeding [140]. In addition, the effects of vitamin K2 [menadione-4 (MK-4)] on the proliferation of rheumatoid synovial cells and the development of arthritis induced by collagen (CIA) were studied, and the results showed that MK-4 inhibited the proliferation of FLSs and the occurrence of CIA in a dose-dependent manner [139]. Furthermore, the toxicity of vitamin K2 is obviously lower than that of other antiproliferative drugs, such as methotrexate (MTX) [141]. Vitamin K also plays an important role in bone health and mineralization, which may support the joint health of RA patients by affecting bone metabolism and reducing arthritis-related bone loss [72]. Therefore, vitamin K2 may constitute a new future strategy for the management of patients with RA.
Other vitamins may also indirectly contribute to the management of RA. For example, vitamin C participates in the synthesis of collagen, which helps to maintain the health of joint tissue [142]. Both vitamin C and vitamin E serve as antioxidants and may reduce the generation of free radicals in joints and further inhibit inflammation and joint injury [143].

3.3.4. Minerals

Minerals such as calcium and phosphorus are closely related with bone health. Reports indicated that minerals level and oxidation stress were also involved in mitigating the symptom of RA [144,145]. Selenium, a recently attractive mineral component, exerts strong antioxidant effects. It is an important composition of selenoproteins, such as glutathione peroxidase (GPx), and contributes to suppressing the inflammatory reaction of RA by inhibiting the nuclear factor-kappa B (NF-κB) cascade and reducing the production of inflammatory mediators [146]. Studies showed that selenium nanoparticles supplementation improved the levels of tissue antioxidant enzymes and exerted anti-inflammatory effects by inactivating Adenosine 5‘-monophosphate (AMP)-activated protein kinase α (AMPKα)/mammalian target of rapamycin (mTOR) signal pathway [147,148]. In general, selenium supplementation contributed to reducing progression and symptoms of RA through suppressing oxidative stress level.

3.3.5. Other Factor

Some dietary ingredients, such as omega-3 polyunsaturated fatty acids, are also involved in RA prevention. Reports have shown that a diet rich in omega-3 fatty acids is responsible for reducing inflammatory reactions and lowering RA-induced pain [149,150]. Supplementation with omega-3 fatty acids contributed to a decrease in the number of tender and swollen joints [39]. However, the effects of omega-3 fatty acids on preventing RA are still controversial. A meta-analysis revealed no beneficial effect of omega-3 fatty acid consumption on decreasing the risk of RA occurrence [151]. There is a need for longer durations and well-designed studies to further evaluate the influence of omega-3 fatty acid consumption on RA occurrence.

4. Conclusions

This review summarizes the pathogenesis of rheumatoid arthritis and the influence of different dietary patterns on RA. RA is a complex autoimmune disease, and its pathogenesis involves an inflammatory response and immune system disorders. Increasing evidence shows that a high-fat, high-sugar, and high-salt diet may promote the progression of RA, whereas a Mediterranean diet is considered to have a positive effect on RA. In addition, food ingredients, such as dietary fiber, probiotics, and vitamins, potentially reduce inflammation and relieve joint pain, which may play a key role in the treatment of RA. Although dietary modification may improve the quality of life of patients, the available evidence does not prove that dietary intervention can replace pharmacological treatment for RA.
Although detailed studies of the relationships between human dietary intake and immune and inflammatory pathways in RA are lacking, different underlying mechanisms have been proposed in vitro or in animal models. Therefore, diet may become an adjuvant therapy for standard RA treatment in the future, and it is suggested that patients with rheumatoid arthritis adopt a healthy lifestyle and nutritional strategy. Moreover, we should continue to explore the role and mechanism of the effects of diet on RA in the future and provide reliable guidance for the diet management of individuals with RA.

Author Contributions

J.Z.: Writing—original draft. X.W.: Writing—original draft. J.F.: Writing—review and editing. Y.L.: Writing—review and editing. Y.Y.: Writing—review and editing. J.W.: Writing—review and editing. B.S.: Writing—review and editing. All authors have read and agreed to the published version of the manuscript.

Funding

This research was funded by the National Natural Science Foundation of China (grant number 32401988), the Beijing Nova Program (grant number 20240484678), and the National Key R&D Program of China (grant number 2022YFF1100204).

Conflicts of Interest

The authors declare no conflicts of interest.

Abbreviations

The following abbreviations are used in this manuscript:
RARheumatoid arthritis
MDMediterranean diet
HLAHuman leucocyte antigen
PTPN22Protein tyrosine phosphatase, non-receptor type 22
CTLA-4Cytotoxic T lymphocyte-associated antigen-4
CRPC-reaction protein
ILInterleukin
TNFTumor necrosis factor
MMPMetalloproteinase
AGEsAdvanced glycation end products
SGK1Serum glucocorticoid kinase
DASHDietary Approaches to Stop Hypertension
LDLLow-density lipoprotein
HDLHigh-density lipoprotein
IDFInsoluble dietary fiber
SDFSoluble dietary fiber
SCFAsShort-chain fatty acids
MTXMethotrexate
MK-4Menadione-4
CIAArthritis induced by collagen
AMPKAdenosine 5‘-monophosphate (AMP)-activated protein kinase
mTORMammalian target of rapamycin

References

  1. Smolen, J.S.; Aletaha, D.; McInnes, I.B. Rheumatoid arthritis. Lancet 2016, 388, 2023–2038. [Google Scholar] [CrossRef] [PubMed]
  2. Mcinnes, I.B.; Schett, G. The pathogenesis of rheumatoid arthritis. Mass. Med. Soc. 2011, 365, 2205–2219. [Google Scholar] [CrossRef]
  3. Cross, M.; Smith, E.; Hoy, D.; Carmona, L.; Wolfe, F.; Vos, T.; Williams, B.; Gabriel, S.; Lassere, M.; Johns, N.; et al. The global burden of rheumatoid arthritis: Estimates from the global burden of disease 2010 study. Ann. Rheum. Dis. 2014, 73, 1316–1322. [Google Scholar] [CrossRef]
  4. Rosa-Gonçalves, D.; Bernardes, M.; Costa, L. Quality of life and functional capacity in patients with rheumatoid arthritis-Cross-sectional study. Reum. Clin. (Engl. Ed.) 2018, 14, 360–366. [Google Scholar]
  5. Safiri, S.; Kolahi, A.A.; Hoy, D.; Smith, E.; Bettampadi, D.; Mansournia, M.A.; Almasi-Hashiani, A.; Ashrafi-Asgarabad, A.; Moradi-Lakeh, M.; Qorbani, M.; et al. Global, regional and national burden of rheumatoid arthritis 1990–2017: A systematic analysis of the Global Burden of Disease study 2017. Ann. Rheum. Dis. 2019, 78, 1463–1471. [Google Scholar] [CrossRef] [PubMed]
  6. Global, regional, and national burden of rheumatoid arthritis, 1990–2020, and projections to 2050: A systematic analysis of the Global Burden of Disease Study 2021. Lancet Rheumatol. 2023, 5, e594–e610. [CrossRef] [PubMed]
  7. Firestein, G.S.; McInnes, I.B. Immunopathogenesis of Rheumatoid Arthritis. Immunity 2017, 46, 183–196. [Google Scholar] [CrossRef]
  8. van Heemst, J.; van der Woude, D.; Huizinga, T.W.; Toes, R.E. HLA and rheumatoid arthritis: How do they connect? Ann. Med. 2014, 46, 304–310. [Google Scholar] [CrossRef]
  9. Charpin, C.; Balandraud, N.; Guis, S.; Roudier, C.; Toussirot, E.; Rak, J.; Lambert, N.; Martin, M.; Reviron, D.; Roudier, J.; et al. HLA-DRB1*0404 is strongly associated with high titers of anti-cyclic citrullinated peptide antibodies in rheumatoid arthritis. Clin. Exp. Rheumatol. 2008, 26, 627–631. [Google Scholar]
  10. Rodríguez-Fernández, J.L. Antigen presentation by dendritic cells in rheumatoid arthritis. Curr. Top. Med. Chem. 2013, 13, 712–719. [Google Scholar] [CrossRef]
  11. Berthelot, J.M.; Darrieutort-Laffite, C.; Le Goff, B. Contribution of HLA DRB1, PTPN22, and CTLA4, to RA dysbiosis. Jt. Bone Spine 2022, 89, 105446. [Google Scholar] [CrossRef] [PubMed]
  12. Venetsanopoulou, A.I.; Alamanos, Y.; Voulgari, P.V.; Drosos, A.A. Epidemiology of rheumatoid arthritis: Genetic and environmental influences. Expert. Rev. Clin. Immunol. 2022, 18, 923–931. [Google Scholar] [CrossRef]
  13. Arleevskaya, M.I.; Manukyan, G.; Inoue, R.; Aminov, R. Editorial: Microbial and Environmental Factors in Autoimmune and Inflammatory Diseases. Front. Immunol. 2017, 8, 243. [Google Scholar] [CrossRef] [PubMed]
  14. Christman, L.M.; Gu, L. Efficacy and mechanisms of dietary polyphenols in mitigating rheumatoid arthritis. J. Funct. Foods 2020, 71, 104003. [Google Scholar] [CrossRef]
  15. Giannini, D.; Antonucci, M.; Petrelli, F.; Bilia, S.; Alunno, A.; Puxeddu, I. One year in review 2020: Pathogenesis of rheumatoid arthritis. Clin. Exp. Rheumatol. 2020, 38, 387–397. [Google Scholar] [CrossRef]
  16. Hitchon, C.A.; Chandad, F.; Ferucci, E.D.; Willemze, A.; Ioan-Facsinay, A.; van der Woude, D.; Markland, J.; Robinson, D.; Elias, B.; Newkirk, M.; et al. Antibodies to porphyromonas gingivalis are associated with anticitrullinated protein antibodies in patients with rheumatoid arthritis and their relatives. J. Rheumatol. 2010, 37, 1105–1112. [Google Scholar] [CrossRef]
  17. Kjeldsen-Kragh, J.; Rashid, T.; Dybwad, A.; Sioud, M.; Haugen, M.; Førre, O.; Ebringer, A. Decrease in anti-Proteus mirabilis but not anti-Escherichia coli antibody levels in rheumatoid arthritis patients treated with fasting and a one year vegetarian diet. Ann. Rheum. Dis. 1995, 54, 221–224. [Google Scholar] [CrossRef]
  18. Blaschke, S.; Schwarz, G.; Moneke, D.; Binder, L.; Müller, G.; Reuss-Borst, M. Epstein-Barr virus infection in peripheral blood mononuclear cells, synovial fluid cells, and synovial membranes of patients with rheumatoid arthritis. J. Rheumatol. 2000, 27, 866–873. [Google Scholar]
  19. da Rocha Sobrinho, H.M.; Jarach, R.; da Silva, N.A.; Shio, M.T.; Jancar, S.; Timenetsky, J.; Oliveira, M.A.; Dorta, M.L.; Ribeiro-Dias, F. Mycoplasmal lipid-associated membrane proteins and Mycoplasma arthritidis mitogen recognition by serum antibodies from patients with rheumatoid arthritis. Rheumatol. Int. 2011, 31, 951–957. [Google Scholar] [CrossRef]
  20. Parks, C.G.; Hoppin, J.A.; De Roos, A.J.; Costenbader, K.H.; Alavanja, M.C.; Sandler, D.P. Rheumatoid Arthritis in Agricultural Health Study Spouses: Associations with Pesticides and Other Farm Exposures. Environ. Health Perspect. 2016, 124, 1728–1734. [Google Scholar] [CrossRef]
  21. Solomon, D.H.; Reed, G.W.; Kremer, J.M.; Curtis, J.R.; Farkouh, M.E.; Harrold, L.R.; Hochberg, M.C.; Tsao, P.; Greenberg, J.D. Disease activity in rheumatoid arthritis and the risk of cardiovascular events. Arthritis Rheumatol. 2015, 67, 1449–1455. [Google Scholar] [CrossRef] [PubMed]
  22. England, B.R.; Thiele, G.M.; Anderson, D.R.; Mikuls, T.R. Increased cardiovascular risk in rheumatoid arthritis: Mechanisms and implications. BMJ 2018, 361, k1036. [Google Scholar] [CrossRef]
  23. Liu, Y.; Hazlewood, G.S.; Kaplan, G.G.; Eksteen, B.; Barnabe, C. Impact of Obesity on Remission and Disease Activity in Rheumatoid Arthritis: A Systematic Review and Meta-Analysis. Arthritis Care Res. 2017, 69, 157–165. [Google Scholar] [CrossRef] [PubMed]
  24. Moroni, L.; Farina, N.; Dagna, L. Obesity and its role in the management of rheumatoid and psoriatic arthritis. Clin. Rheumatol. 2020, 39, 1039–1047. [Google Scholar] [CrossRef]
  25. Rosillo, M.A.; Alarcón-de-la-Lastra, C.; Sánchez-Hidalgo, M. An update on dietary phenolic compounds in the prevention and management of rheumatoid arthritis. Food Funct. 2016, 7, 2943–2969. [Google Scholar] [CrossRef]
  26. Dessein, P.H.; Stanwix, A.E.; Solomon, A. How Could Physical Activity Reduce Inflammation and Inflammatory Gene Expression in Rheumatoid Arthritis? J. Rheumatol. 2022, 49, 1299–1302. [Google Scholar] [CrossRef]
  27. Bungau, S.G.; Behl, T.; Singh, A.; Sehgal, A.; Singh, S.; Chigurupati, S.; Vijayabalan, S.; Das, S.; Palanimuthu, V.R. Targeting Probiotics in Rheumatoid Arthritis. Nutrients 2021, 13, 3376. [Google Scholar] [CrossRef]
  28. Metsios, G.S.; Kitas, G.D. Physical activity, exercise and rheumatoid arthritis: Effectiveness, mechanisms and implementation. Best. Pract. Res. Clin. Rheumatol. 2018, 32, 669–682. [Google Scholar] [CrossRef] [PubMed]
  29. Zhang, X.; Zhang, X.; Yang, Y.; Zhi, K.; Chen, Y.; Zhao, J.; Cui, W.; Zhao, X.; Zhang, Z.; An, Y.; et al. Association between passive smoking and the risk of rheumatoid arthritis: A systematic review and meta-analysis. Clin. Rheumatol. 2023, 42, 663–672. [Google Scholar] [CrossRef]
  30. Hu, H.; Xu, A.; Gao, C.; Wang, Z.; Wu, X. The effect of physical exercise on rheumatoid arthritis: An overview of systematic reviews and meta-analysis. J. Adv. Nurs. 2021, 77, 506–522. [Google Scholar] [CrossRef]
  31. Swardh, E.; Brodin, N. Effects of aerobic and muscle strengthening exercise in adults with rheumatoid arthritis: A narrative review summarising a chapter in Physical activity in the prevention and treatment of disease (FYSS 2016). Br. J. Sports Med. 2016, 50, 362–367. [Google Scholar] [CrossRef] [PubMed]
  32. Alghamdi, M.A.; Redwan, E.M. Interplay of Microbiota and Citrullination in the Immunopathogenesis of Rheumatoid Arthritis. Probiotics Antimicrob. Proteins 2022, 14, 99–113. [Google Scholar] [CrossRef]
  33. Klein, S.L.; Flanagan, K.L. Sex differences in immune responses. Nat. Rev. Immunol. 2016, 16, 626–638. [Google Scholar] [CrossRef]
  34. Johansson, K.; Askling, J.; Alfredsson, L.; Di Giuseppe, D. Mediterranean diet and risk of rheumatoid arthritis: A population-based case-control study. Arthritis Res. Ther. 2018, 20, 175. [Google Scholar]
  35. Skoczyńska, M.; Świerkot, J. The role of diet in rheumatoid arthritis. Reumatologia 2018, 56, 259–267. [Google Scholar] [CrossRef] [PubMed]
  36. Gioia, C.; Lucchino, B.; Tarsitano, M.G.; Iannuccelli, C.; Di Franco, M. Dietary Habits and Nutrition in Rheumatoid Arthritis: Can Diet Influence Disease Development and Clinical Manifestations? Nutrients 2020, 12, 1456. [Google Scholar] [CrossRef]
  37. Manzel, A.; Muller, D.N.; Hafler, D.A.; Erdman, S.E.; Linker, R.A.; Kleinewietfeld, M. Role of “Western diet” in inflammatory autoimmune diseases. Curr. Allergy Asthma Rep. 2014, 14, 404. [Google Scholar] [CrossRef]
  38. Calder, P.C. Omega-3 fatty acids and inflammatory processes: From molecules to man. Biochem. Soc. Trans. 2017, 45, 1105–1115. [Google Scholar] [CrossRef] [PubMed]
  39. Kostoglou-Athanassiou, I.; Athanassiou, L.; Athanassiou, P. The Effect of Omega-3 Fatty Acids on Rheumatoid Arthritis. Mediterr. J. Rheumatol. 2020, 31, 190–194. [Google Scholar] [CrossRef]
  40. Zorgetto-Pinheiro, V.A.; Machate, D.J.; Figueiredo, P.S.; Marcelino, G.; Hiane, P.A.; Pott, A.; Guimaraes, R.C.A.; Bogo, D. Omega-3 Fatty Acids and Balanced Gut Microbiota on Chronic Inflammatory Diseases: A Close Look at Ulcerative Colitis and Rheumatoid Arthritis Pathogenesis. J. Med. Food 2022, 25, 341–354. [Google Scholar] [CrossRef]
  41. Jalili, M.; Hekmatdoost, A. Dietary omega-3 fatty acids and their influence on inflammation via Toll-like receptor pathways. Nutrition 2021, 85, 111070. [Google Scholar] [CrossRef] [PubMed]
  42. Bellan, M.; Sainaghi, P.P.; Pirisi, M. Role of Vitamin D in Rheumatoid Arthritis. Adv. Exp. Med. Biol. 2017, 996, 155–168. [Google Scholar] [PubMed]
  43. Moradi, A.; Nezamoleslami, S.; Nezamoleslami, S.; Clark, C.C.T.; Sohouli, M.H.; Ghiasvand, R. The association between dietary total antioxidant capacity with risk of rheumatoid arthritis in adults: A case-control study. Clin. Nutr. ESPEN 2022, 51, 391–396. [Google Scholar] [CrossRef] [PubMed]
  44. Liu, L.; Xie, S. Dietary fiber intake associated with risk of rheumatoid arthritis among U.S. adults: NHANES 2010–2020. Medicine 2023, 102, e33357. [Google Scholar] [CrossRef]
  45. Rasouli-Saravani, A.; Jahankhani, K.; Moradi, S.; Gorgani, M.; Shafaghat, Z.; Mirsanei, Z.; Mehmandar, A.; Mirzaei, R. Role of microbiota short-chain fatty acids in the pathogenesis of autoimmune diseases. Biomed. Pharmacother. 2023, 162, 114620. [Google Scholar] [CrossRef]
  46. Coutant, F.; Miossec, P. Evolving concepts of the pathogenesis of rheumatoid arthritis with focus on the early and late stages. Curr. Opin. Rheumatol. 2020, 32, 57–63. [Google Scholar] [CrossRef]
  47. Scherer, H.U.; Haupl, T.; Burmester, G.R. The etiology of rheumatoid arthritis. J. Autoimmun. 2020, 110, 102400. [Google Scholar] [CrossRef]
  48. de Hair, M.J.; van de Sande, M.G.; Ramwadhdoebe, T.H.; Hansson, M.; Landewé, R.; van der Leij, C.; Maas, M.; Serre, G.; van Schaardenburg, D.; Klareskog, L.; et al. Features of the synovium of individuals at risk of developing rheumatoid arthritis: Implications for understanding preclinical rheumatoid arthritis. Arthritis Rheumatol. 2014, 66, 513–522. [Google Scholar] [CrossRef]
  49. Elshabrawy, H.A.; Chen, Z.; Volin, M.V.; Ravella, S.; Virupannavar, S.; Shahrara, S. The pathogenic role of angiogenesis in rheumatoid arthritis. Angiogenesis 2015, 18, 433–448. [Google Scholar] [CrossRef]
  50. Mehana, E.E.; Khafaga, A.F.; El-Blehi, S.S. The role of matrix metalloproteinases in osteoarthritis pathogenesis: An updated review. Life Sci. 2019, 234, 116786. [Google Scholar] [CrossRef]
  51. Goldring, M.B.; Otero, M. Inflammation in osteoarthritis. Curr. Opin. Rheumatol. 2011, 23, 471–478. [Google Scholar] [CrossRef] [PubMed]
  52. Pulik, L.; Legosz, P.; Motyl, G. Matrix metalloproteinases in rheumatoid arthritis and osteoarthritis: A state of the art review. Reumatologia 2023, 61, 191–201. [Google Scholar] [CrossRef]
  53. Conforti, A.; Di Cola, I.; Pavlych, V.; Ruscitti, P.; Berardicurti, O.; Ursini, F.; Giacomelli, R.; Cipriani, P. Beyond the joints, the extra-articular manifestations in rheumatoid arthritis. Autoimmun. Rev. 2021, 20, 102735. [Google Scholar] [CrossRef]
  54. Kapoor, M.; Martel-Pelletier, J.; Lajeunesse, D.; Pelletier, J.P.; Fahmi, H. Role of proinflammatory cytokines in the pathophysiology of osteoarthritis. Nat. Rev. Rheumatol. 2011, 7, 33–42. [Google Scholar] [CrossRef] [PubMed]
  55. Yamaguchi, M.; Praditsorn, P.; Purnamasari, S.D.; Sranacharoenpong, K.; Arai, Y.; Sundermeir, S.M.; Gittelsohn, J.; Hadi, H.; Nishi, N. Measures of Perceived Neighborhood Food Environments and Dietary Habits: A Systematic Review of Methods and Associations. Nutrients 2022, 14, 1788. [Google Scholar] [CrossRef] [PubMed]
  56. Bouchard-Mercier, A.; Paradis, A.M.; Rudkowska, I.; Lemieux, S.; Couture, P.; Vohl, M.C. Associations between dietary patterns and gene expression profiles of healthy men and women: A cross-sectional study. Nutr. J. 2013, 12, 24. [Google Scholar] [CrossRef]
  57. Xia, Y.; Gu, Y.; Yu, F.; Zhang, Q.; Liu, L.; Meng, G.; Wu, H.; Du, H.; Shi, H.; Guo, X.; et al. Association between dietary patterns and metabolic syndrome in Chinese adults: A propensity score-matched case-control study. Sci. Rep. 2016, 6, 34748. [Google Scholar] [CrossRef]
  58. Deahl-Greenlaw, A.; Marks, S. Meeting the New 2015–2020 Dietary Guidelines for Americans. Dela. J. Public Health 2016, 2, 22–23. [Google Scholar] [CrossRef]
  59. Bovolini, A.; Garcia, J.; Andrade, M.A.; Duarte, J.A. Metabolic Syndrome Pathophysiology and Predisposing Factors. Int. J. Sports Med. 2021, 42, 199–214. [Google Scholar] [CrossRef]
  60. Bäcklund, R.; Drake, I.; Bergström, U.; Compagno, M.; Sonestedt, E.; Turesson, C. Diet and the risk of rheumatoid arthritis-A systematic literature review. Semin. Arthritis Rheum. 2023, 58, 152118. [Google Scholar] [CrossRef]
  61. Rohr, M.W.; Narasimhulu, C.A.; Rudeski-Rohr, T.A.; Parthasarathy, S. Negative Effects of a High-Fat Diet on Intestinal Permeability: A Review. Adv. Nutr. 2020, 11, 77–91. [Google Scholar] [CrossRef]
  62. Liu, Y.; Zhang, Y.; Zhang, J.; Ren, S.; Cao, Q.; Kong, H.; Xu, Q.; Liu, R. High-fat diet stimulated butyric acid metabolism dysbiosis, altered microbiota, and aggravated inflammatory response in collagen-induced arthritis rats. Nutr. Metab. 2024, 21, 95. [Google Scholar] [CrossRef]
  63. Min, Y.; Heo, Y.; Feng, F.; Kim, D.; Kim, M.; Yang, J.; Kim, H.J.; Jee, Y.; Ghosh, M.; Kang, I.; et al. High-Sucrose Diet Accelerates Arthritis Progression in a Collagen-Induced Rheumatoid Arthritis Model. Mol. Nutr. Food Res. 2023, 67, e2300244. [Google Scholar] [CrossRef] [PubMed]
  64. Yokota, K.; Sato, K.; Miyazaki, T.; Kitaura, H.; Kayama, H.; Miyoshi, F.; Araki, Y.; Akiyama, Y.; Takeda, K.; Mimura, T. Combination of tumor necrosis factor alpha and interleukin-6 induces mouse osteoclast-like cells with bone resorption activity both in vitro and in vivo. Arthritis Rheumatol. 2014, 66, 121–129. [Google Scholar] [CrossRef] [PubMed]
  65. van der Meer, J.W.; Netea, M.G. A salty taste to autoimmunity. N. Engl. J. Med. 2013, 368, 2520–2521. [Google Scholar] [CrossRef] [PubMed]
  66. Sharif, K.; Amital, H.; Shoenfeld, Y. The role of dietary sodium in autoimmune diseases: The salty truth. Autoimmun. Rev. 2018, 17, 1069–1073. [Google Scholar] [CrossRef]
  67. Hager, J.; Bang, H.; Hagen, M.; Frech, M.; Trager, P.; Sokolova, M.V.; Steffen, U.; Tascilar, K.; Sarter, K.; Schett, G.; et al. The Role of Dietary Fiber in Rheumatoid Arthritis Patients: A Feasibility Study. Nutrients 2019, 11, 2392. [Google Scholar] [CrossRef]
  68. Bai, Y.; Li, Y.; Marion, T.; Tong, Y.; Zaiss, M.M.; Tang, Z.; Zhang, Q.; Liu, Y.; Luo, Y. Resistant starch intake alleviates collagen-induced arthritis in mice by modulating gut microbiota and promoting concomitant propionate production. J. Autoimmun. 2021, 116, 102564. [Google Scholar] [CrossRef]
  69. Vaghef-Mehrabany, E.; Alipour, B.; Homayouni-Rad, A.; Sharif, S.K.; Asghari-Jafarabadi, M.; Zavvari, S. Probiotic supplementation improves inflammatory status in patients with rheumatoid arthritis. Nutrition 2014, 30, 430–435. [Google Scholar] [CrossRef]
  70. Mohammed, A.T.; Khattab, M.; Ahmed, A.M.; Turk, T.; Sakr, N.; Adham, M.K.; Abdelhalim, M.; Sawaf, B.; Hirayama, K.; Huy, N.T. The therapeutic effect of probiotics on rheumatoid arthritis: A systematic review and meta-analysis of randomized control trials. Clin. Rheumatol. 2017, 36, 2697–2707. [Google Scholar] [CrossRef]
  71. Zhang, Y.; Li, S.; Zhuo, F.; Wang, H.; Geng, X.; Xu, B.; Yin, L.; Sun, H.; Yan, X. Additive Effects of VDBP and 1,25(OH)2D3 on the Viability and Apoptosis of Rheumatoid Arthritis Synovial Fibroblasts. Front. Endocrinol. 2020, 11, 583229. [Google Scholar] [CrossRef]
  72. Shea, M.K.; Kritchevsky, S.B.; Hsu, F.C.; Nevitt, M.; Booth, S.L.; Kwoh, C.K.; McAlindon, T.E.; Vermeer, C.; Drummen, N.; Harris, T.B.; et al. The association between vitamin K status and knee osteoarthritis features in older adults: The Health, Aging and Body Composition Study. Osteoarthr. Cartil. 2015, 23, 370–378. [Google Scholar] [CrossRef]
  73. Krisanits, B.; Randise, J.F.; Burton, C.E.; Findlay, V.J.; Turner, D.P. Pubertal mammary development as a “susceptibility window” for breast cancer disparity. Adv. Cancer Res. 2020, 146, 57–82. [Google Scholar]
  74. Snetselaar, L.G.; de Jesus, J.M.; DeSilva, D.M.; Stoody, E.E. Dietary Guidelines for Americans, 2020–2025: Understanding the Scientific Process, Guidelines, and Key Recommendations. Nutr Today 2021, 56, 287–295. [Google Scholar] [CrossRef] [PubMed]
  75. Eckel-Mahan, K.L.; Patel, V.R.; de Mateo, S.; Orozco-Solis, R.; Ceglia, N.J.; Sahar, S.; Dilag-Penilla, S.A.; Dyar, K.A.; Baldi, P.; Sassone-Corsi, P. Reprogramming of the circadian clock by nutritional challenge. Cell 2013, 155, 1464–1478. [Google Scholar] [CrossRef] [PubMed]
  76. Rhea, E.M.; Salameh, T.S.; Logsdon, A.F.; Hanson, A.J.; Erickson, M.A.; Banks, W.A. Blood-Brain Barriers in Obesity. AAPS J. 2017, 19, 921–930. [Google Scholar] [CrossRef] [PubMed]
  77. Liang, J.; Yang, K.; Shen, Y.; Peng, X.; Tan, H.; Liu, L.; Xie, Q.; Wang, Y. Incidence of collagen-induced arthritis is elevated by a high-fat diet without influencing body weight in mice. RMD Open 2024, 10, e003869. [Google Scholar] [CrossRef]
  78. Iannone, F.; Fanizzi, R.; Notarnicola, A.; Scioscia, C.; Anelli, M.G.; Lapadula, G. Obesity reduces the drug survival of second line biological drugs following a first TNF-α inhibitor in rheumatoid arthritis patients. Jt. Bone Spine 2015, 82, 187–191. [Google Scholar] [CrossRef]
  79. Jhun, J.Y.; Yoon, B.Y.; Park, M.K.; Oh, H.J.; Byun, J.K.; Lee, S.Y.; Min, J.K.; Park, S.H.; Kim, H.Y.; Cho, M.L. Obesity aggravates the joint inflammation in a collagen-induced arthritis model through deviation to Th17 differentiation. Exp. Mol. Med. 2012, 44, 424–431. [Google Scholar] [CrossRef]
  80. Kim, S.J.; Chen, Z.; Essani, A.B.; Elshabrawy, H.A.; Volin, M.V.; Fantuzzi, G.; McInnes, I.B.; Baker, J.F.; Finn, P.; Kondos, G.; et al. Differential impact of obesity on the pathogenesis of RA or preclinical models is contingent on the disease status. Ann. Rheum. Dis. 2017, 76, 731–739. [Google Scholar] [CrossRef]
  81. Turesson, C.; Bergstrom, U.; Pikwer, M.; Nilsson, J.A.; Jacobsson, L.T. High serum cholesterol predicts rheumatoid arthritis in women, but not in men: A prospective study. Arthritis Res. Ther. 2015, 17, 284. [Google Scholar] [CrossRef]
  82. Turesson, C.; Bergström, U.; Pikwer, M.; Nilsson, J.; Jacobsson, L.T. A high body mass index is associated with reduced risk of rheumatoid arthritis in men, but not in women. Rheumatology 2016, 55, 307–314. [Google Scholar] [CrossRef]
  83. Zhang, W.; Ma, X.; Cheng, H.; Zhang, D.F. [Research Progress in High-Sugar Diet and Inflammatory Diseases]. Sichuan Da Xue Xue Bao Yi Xue Ban 2022, 53, 538–542. [Google Scholar]
  84. WHO Guidelines Approved by the Guidelines Review Committee. In Guideline: Sugars Intake for Adults and Children; World Health Organization: Geneva, Switzerland, 2015.
  85. Bantle, J.P.; Wylie-Rosett, J.; Albright, A.L.; Apovian, C.M.; Clark, N.G.; Franz, M.J.; Hoogwerf, B.J.; Lichtenstein, A.H.; Mayer-Davis, E.; Mooradian, A.D.; et al. Nutrition recommendations and interventions for diabetes: A position statement of the American Diabetes Association. Diabetes Care 2008, 31 (Suppl. S1), S61–S78. [Google Scholar] [PubMed]
  86. Malik, V.S.; Popkin, B.M.; Bray, G.A.; Després, J.P.; Willett, W.C.; Hu, F.B. Sugar-sweetened beverages and risk of metabolic syndrome and type 2 diabetes: A meta-analysis. Diabetes Care 2010, 33, 2477–2483. [Google Scholar] [CrossRef] [PubMed]
  87. Drewnowski, A.; Almiron-Roig, E. Frontiers in Neuroscience Human Perceptions and Preferences for Fat-Rich Foods. In Fat Detection: Taste, Texture, and Post Ingestive Effects; Montmayeur, J.P., le Coutre, J., Eds.; Taylor & Francis Group, LLC.: Boca Raton, FL, USA, 2010. [Google Scholar]
  88. Te Morenga, L.; Mallard, S.; Mann, J. Dietary sugars and body weight: Systematic review and meta-analyses of randomised controlled trials and cohort studies. BMJ 2012, 346, e7492. [Google Scholar] [CrossRef]
  89. Stanhope, K.L. Sugar consumption, metabolic disease and obesity: The state of the controversy. Crit. Rev. Clin. Lab. Sci. 2016, 53, 52–67. [Google Scholar] [CrossRef] [PubMed]
  90. Powell-Wiley, T.M.; Poirier, P.; Burke, L.E.; Després, J.P.; Gordon-Larsen, P.; Lavie, C.J.; Lear, S.A.; Ndumele, C.E.; Neeland, I.J.; Sanders, P.; et al. Obesity and Cardiovascular Disease: A Scientific Statement From the American Heart Association. Circulation 2021, 143, e984–e1010. [Google Scholar] [CrossRef]
  91. Hu, Y.; Costenbader, K.H.; Gao, X.; Al-Daabil, M.; Sparks, J.A.; Solomon, D.H.; Hu, F.B.; Karlson, E.W.; Lu, B. Sugar-sweetened soda consumption and risk of developing rheumatoid arthritis in women. Am. J. Clin. Nutr. 2014, 100, 959–967. [Google Scholar] [CrossRef]
  92. Zheng, Y.; Ley, S.H.; Hu, F.B. Global aetiology and epidemiology of type 2 diabetes mellitus and its complications. Nat. Rev. Endocrinol. 2018, 14, 88–98. [Google Scholar] [CrossRef]
  93. Laiguillon, M.C.; Courties, A.; Houard, X.; Auclair, M.; Sautet, A.; Capeau, J.; Fève, B.; Berenbaum, F.; Sellam, J. Characterization of diabetic osteoarthritic cartilage and role of high glucose environment on chondrocyte activation: Toward pathophysiological delineation of diabetes mellitus-related osteoarthritis. Osteoarthr. Cartil. 2015, 23, 1513–1522. [Google Scholar] [CrossRef] [PubMed]
  94. Espino-Gonzalez, E.; Dalbram, E.; Mounier, R.; Gondin, J.; Farup, J.; Jessen, N.; Treebak, J.T. Impaired skeletal muscle regeneration in diabetes: From cellular and molecular mechanisms to novel treatments. Cell Metab. 2024, 36, 1204–1236. [Google Scholar] [PubMed]
  95. Dieppe, P. Epidemiology of the Rheumatic Diseases Second Edition. Silman, A.J., Hochberg, M.C., Eds.; Oxford University Press: Oxford, UK, 2001; p. 377, ISBN: 0192631497. Int. J. Epidemiol. 2002, 31, 1079–1080. [Google Scholar] [CrossRef]
  96. Zhang, Y.; Pool, A.H.; Wang, T.; Liu, L.; Kang, E.; Zhang, B.; Ding, L.; Frieda, K.; Palmiter, R.; Oka, Y. Parallel neural pathways control sodium consumption and taste valence. Cell 2023, 186, 5751–5765.e16. [Google Scholar] [CrossRef]
  97. Kaldor, J.C.; Thow, A.M.; Schönfeldt, H. Using regulation to limit salt intake and prevent non-communicable diseases: Lessons from South Africa’s experience. Public Health Nutr. 2019, 22, 1316–1325. [Google Scholar] [CrossRef]
  98. WHO Guidelines Approved by the Guidelines Review Committee. In Guideline: Sodium Intake for Adults and Children; World Health Organization: Geneva, Switzerland, 2012.
  99. Salgado, E.; Bes-Rastrollo, M.; de Irala, J.; Carmona, L.; Gómez-Reino, J.J. High Sodium Intake Is Associated With Self-Reported Rheumatoid Arthritis: A Cross Sectional and Case Control Analysis Within the SUN Cohort. Medicine 2015, 94, e0924. [Google Scholar] [CrossRef] [PubMed]
  100. Sundström, B.; Johansson, I.; Rantapää-Dahlqvist, S. Interaction between dietary sodium and smoking increases the risk for rheumatoid arthritis: Results from a nested case-control study. Rheumatology 2015, 54, 487–493. [Google Scholar] [CrossRef]
  101. Shams-White, M.M.; Pannucci, T.E.; Lerman, J.L.; Herrick, K.A.; Zimmer, M.; Meyers Mathieu, K.; Stoody, E.E.; Reedy, J. Healthy Eating Index-2020: Review and Update Process to Reflect the Dietary Guidelines for Americans, 2020–2025. J. Acad. Nutr. Diet. 2023, 123, 1280–1288. [Google Scholar] [CrossRef] [PubMed]
  102. Estruch, R.; Ros, E.; Salas-Salvadó, J.; Covas, M.I.; Corella, D.; Arós, F.; Gómez-Gracia, E.; Ruiz-Gutiérrez, V.; Fiol, M.; Lapetra, J.; et al. Primary Prevention of Cardiovascular Disease with a Mediterranean Diet Supplemented with Extra-Virgin Olive Oil or Nuts. N. Engl. J. Med. 2018, 378, e34. [Google Scholar] [CrossRef]
  103. Filippou, C.D.; Tsioufis, C.P.; Thomopoulos, C.G.; Mihas, C.C.; Dimitriadis, K.S.; Sotiropoulou, L.I.; Chrysochoou, C.A.; Nihoyannopoulos, P.I.; Tousoulis, D.M. Dietary Approaches to Stop Hypertension (DASH) Diet and Blood Pressure Reduction in Adults with and without Hypertension: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. Adv. Nutr. 2020, 11, 1150–1160. [Google Scholar] [CrossRef]
  104. Melina, V.; Craig, W.; Levin, S. Position of the Academy of Nutrition and Dietetics: Vegetarian Diets. J. Acad. Nutr. Diet. 2016, 116, 1970–1980. [Google Scholar] [CrossRef]
  105. Vitiello, V.; Germani, A.; Capuzzo Dolcetta, E.; Donini, L.M.; Del Balzo, V. The New Modern Mediterranean Diet Italian Pyramid. Ann. Ig. Med. Prev. Comunita 2016, 28, 179–186. [Google Scholar]
  106. Sofi, F.; Macchi, C.; Abbate, R.; Gensini, G.F.; Casini, A. Mediterranean diet and health status: An updated meta-analysis and a proposal for a literature-based adherence score. Public. Health Nutr. 2014, 17, 2769–2782. [Google Scholar] [CrossRef] [PubMed]
  107. Di Daniele, N.; Noce, A.; Vidiri, M.F.; Moriconi, E.; Marrone, G.; Annicchiarico-Petruzzelli, M.; D’Urso, G.; Tesauro, M.; Rovella, V.; De Lorenzo, A. Impact of Mediterranean diet on metabolic syndrome, cancer and longevity. Oncotarget 2017, 8, 8947–8979. [Google Scholar] [CrossRef] [PubMed]
  108. Davis, C.; Bryan, J.; Hodgson, J.; Murphy, K. Definition of the Mediterranean Diet; a Literature Review. Nutrients 2015, 7, 9139–9153. [Google Scholar] [CrossRef]
  109. Kiani, A.K.; Medori, M.C.; Bonetti, G.; Aquilanti, B.; Velluti, V.; Matera, G.; Iaconelli, A.; Stuppia, L.; Connelly, S.T.; Herbst, K.L.; et al. Modern vision of the Mediterranean diet. J. Prev. Med. Hyg. 2022, 63 (Suppl. S3), E36–E43. [Google Scholar]
  110. Tosti, V.; Bertozzi, B.; Fontana, L. Health Benefits of the Mediterranean Diet: Metabolic and Molecular Mechanisms. J. Gerontol. A Biol. Sci. Med. Sci. 2018, 73, 318–326. [Google Scholar] [CrossRef]
  111. Forsyth, C.; Kouvari, M.; D’Cunha, N.M.; Georgousopoulou, E.N.; Panagiotakos, D.B.; Mellor, D.D.; Kellett, J.; Naumovski, N. The effects of the Mediterranean diet on rheumatoid arthritis prevention and treatment: A systematic review of human prospective studies. Rheumatol. Int. 2018, 38, 737–747. [Google Scholar] [CrossRef]
  112. Nikiphorou, E.; Philippou, E. Nutrition and its role in prevention and management of rheumatoid arthritis. Autoimmun. Rev. 2023, 22, 103333. [Google Scholar] [CrossRef]
  113. Blenkinsopp, H.C.; Seidler, K.; Barrow, M. Microbial Imbalance and Intestinal Permeability in the Pathogenesis of Rheumatoid Arthritis: A Mechanism Review with a Focus on Bacterial Translocation, Citrullination, and Probiotic Intervention. J. Am. Nutr. Assoc. 2024, 43, 59–76. [Google Scholar] [CrossRef]
  114. Pitaraki, E.E. The role of Mediterranean diet and its components on the progress of osteoarthritis. J. Frailty Sarcopenia Falls 2017, 2, 45–52. [Google Scholar] [CrossRef]
  115. Kimble, R.; Gouinguenet, P.; Ashor, A.; Stewart, C.; Deighton, K.; Matu, J.; Griffiths, A.; Malcomson, F.C.; Joel, A.; Houghton, D.; et al. Effects of a mediterranean diet on the gut microbiota and microbial metabolites: A systematic review of randomized controlled trials and observational studies. Crit. Rev. Food Sci. Nutr. 2023, 63, 8698–8719. [Google Scholar] [CrossRef] [PubMed]
  116. Amara, A.A.; Shibl, A. Role of Probiotics in health improvement, infection control and disease treatment and management. Saudi Pharm. J. 2015, 23, 107–114. [Google Scholar] [CrossRef] [PubMed]
  117. Slavin, J. Fiber and prebiotics: Mechanisms and health benefits. Nutrients 2013, 5, 1417–1435. [Google Scholar] [CrossRef] [PubMed]
  118. Sofi, F.; Cesari, F.; Abbate, R.; Gensini, G.F.; Casini, A. Adherence to Mediterranean diet and health status: Meta-analysis. BMJ 2008, 337, a1344. [Google Scholar] [CrossRef]
  119. Danneskiold-Samsøe, N.B.; Dias de Freitas Queiroz Barros, H.; Santos, R.; Bicas, J.L.; Cazarin, C.B.B.; Madsen, L.; Kristiansen, K.; Pastore, G.M.; Brix, S.; Maróstica Júnior, M.R. Interplay between food and gut microbiota in health and disease. Food Res. Int. 2019, 115, 23–31. [Google Scholar] [CrossRef]
  120. Zhang, L.; Liu, Y.; Sun, Y.; Zhang, X. Combined Physical Exercise and Diet: Regulation of Gut Microbiota to Prevent and Treat of Metabolic Disease: A Review. Nutrients 2022, 14, 4774. [Google Scholar] [CrossRef]
  121. Gill, P.A.; van Zelm, M.C.; Muir, J.G.; Gibson, P.R. Review article: Short chain fatty acids as potential therapeutic agents in human gastrointestinal and inflammatory disorders. Aliment. Pharmacol. Ther. 2018, 48, 15–34. [Google Scholar] [CrossRef]
  122. Dürholz, K.; Hofmann, J.; Iljazovic, A.; Häger, J.; Lucas, S.; Sarter, K.; Strowig, T.; Bang, H.; Rech, J.; Schett, G.; et al. Dietary Short-Term Fiber Interventions in Arthritis Patients Increase Systemic SCFA Levels and Regulate Inflammation. Nutrients 2020, 12, 3207. [Google Scholar] [CrossRef]
  123. Rosser, E.C.; Piper, C.J.M.; Matei, D.E.; Blair, P.A.; Rendeiro, A.F.; Orford, M.; Alber, D.G.; Krausgruber, T.; Catalan, D.; Klein, N.; et al. Microbiota-Derived Metabolites Suppress Arthritis by Amplifying Aryl-Hydrocarbon Receptor Activation in Regulatory B Cells. Cell Metab. 2020, 31, 837–851.e10. [Google Scholar] [CrossRef]
  124. Mazziotta, C.; Tognon, M.; Martini, F.; Torreggiani, E.; Rotondo, J.C. Probiotics Mechanism of Action on Immune Cells and Beneficial Effects on Human Health. Cells 2023, 12, 184. [Google Scholar] [CrossRef] [PubMed]
  125. Hill, C.; Guarner, F.; Reid, G.; Gibson, G.R.; Merenstein, D.J.; Pot, B.; Morelli, L.; Canani, R.B.; Flint, H.J.; Salminen, S.; et al. Expert consensus document. The International Scientific Association for Probiotics and Prebiotics consensus statement on the scope and appropriate use of the term probiotic. Nat. Rev. Gastroenterol. Hepatol. 2014, 11, 506–514. [Google Scholar] [CrossRef]
  126. Britton, R.A.; Hoffmann, D.E.; Khoruts, A. Probiotics and the Microbiome-How Can We Help Patients Make Sense of Probiotics? Gastroenterology 2021, 160, 614–623. [Google Scholar] [CrossRef] [PubMed]
  127. Fuochi, V.; Furneri, P.M. Applications of Probiotics and Their Potential Health Benefits. Int. J. Mol. Sci. 2023, 24, 15915. [Google Scholar] [CrossRef]
  128. Szajewska, H.; Canani, R.B.; Guarino, A.; Hojsak, I.; Indrio, F.; Kolacek, S.; Orel, R.; Shamir, R.; Vandenplas, Y.; van Goudoever, J.B.; et al. Probiotics for the Prevention of Antibiotic-Associated Diarrhea in Children. J. Pediatr. Gastroenterol. Nutr. 2016, 62, 495–506. [Google Scholar] [CrossRef]
  129. Abdallah, A.; Elemba, E.; Zhong, Q.; Sun, Z. Gastrointestinal Interaction between Dietary Amino Acids and Gut Microbiota: With Special Emphasis on Host Nutrition. Curr. Protein Pept. Sci. 2020, 21, 785–798. [Google Scholar] [CrossRef]
  130. Cryan, J.F.; Dinan, T.G. Mind-altering microorganisms: The impact of the gut microbiota on brain and behaviour. Nat. Rev. Neurosci. 2012, 13, 701–712. [Google Scholar] [CrossRef] [PubMed]
  131. West, C.E.; Jenmalm, M.C.; Prescott, S.L. The gut microbiota and its role in the development of allergic disease: A wider perspective. Clin. Exp. Allergy 2015, 45, 43–53. [Google Scholar] [CrossRef]
  132. Girardin, M.; Frossard, J.L. The role of probiotics in the treatment of inflammatory bowel diseases. Rev. Med. Suisse 2012, 8, 1674–1676, 1678. [Google Scholar]
  133. Zamani, B.; Golkar, H.R.; Farshbaf, S.; Emadi-Baygi, M.; Tajabadi-Ebrahimi, M.; Jafari, P.; Akhavan, R.; Taghizadeh, M.; Memarzadeh, M.R.; Asemi, Z. Clinical and metabolic response to probiotic supplementation in patients with rheumatoid arthritis: A randomized, double-blind, placebo-controlled trial. Int. J. Rheum. Dis. 2016, 19, 869–879. [Google Scholar] [CrossRef]
  134. Yamashita, M.; Matsumoto, K.; Endo, T.; Ukibe, K.; Hosoya, T.; Matsubara, Y.; Nakagawa, H.; Sakai, F.; Miyazaki, T. Preventive Effect of Lactobacillus helveticus SBT2171 on Collagen-Induced Arthritis in Mice. Front. Microbiol. 2017, 8, 1159. [Google Scholar] [CrossRef] [PubMed]
  135. Amdekar, S.; Singh, V.; Kumar, A.; Sharma, P.; Singh, R. Lactobacillus casei and Lactobacillus acidophilus regulate inflammatory pathway and improve antioxidant status in collagen-induced arthritic rats. J. Interferon Cytokine Res. Off. J. Int. Soc. Interferon Cytokine Res. 2013, 33, 1–8. [Google Scholar] [CrossRef] [PubMed]
  136. Holick, M.F. The vitamin D deficiency pandemic: Approaches for diagnosis, treatment and prevention. Rev. Endocr. Metab. Disord. 2017, 18, 153–165. [Google Scholar] [CrossRef]
  137. Haussler, M.R.; Haussler, C.A.; Whitfield, G.K.; Hsieh, J.C.; Thompson, P.D.; Barthel, T.K.; Bartik, L.; Egan, J.B.; Wu, Y.; Kubicek, J.L.; et al. The nuclear vitamin D receptor controls the expression of genes encoding factors which feed the “Fountain of Youth” to mediate healthful aging. J. Steroid Biochem. Mol. Biol. 2010, 121, 88–97. [Google Scholar] [CrossRef]
  138. Lin, Z.; Li, W. The Roles of Vitamin D and Its Analogs in Inflammatory Diseases. Curr. Top. Med. Chem. 2016, 16, 1242–1261. [Google Scholar] [CrossRef] [PubMed]
  139. Azzeh, F.S.; Kensara, O.A. Vitamin D Is a Good Marker for Disease Activity of Rheumatoid Arthritis Disease. Dis. Markers 2015, 2015, 260725. [Google Scholar] [CrossRef]
  140. Tsugawa, N.; Shiraki, M. Vitamin K Nutrition and Bone Health. Nutrients 2020, 12, 1909. [Google Scholar] [CrossRef]
  141. Okamoto, H. Vitamin K and rheumatoid arthritis. IUBMB Life 2008, 60, 355–361. [Google Scholar] [CrossRef]
  142. Meki, A.R.; Hamed, E.A.; Ezam, K.A. Effect of green tea extract and vitamin C on oxidant or antioxidant status of rheumatoid arthritis rat model. Indian. J. Clin. Biochem. 2009, 24, 280–287. [Google Scholar] [CrossRef]
  143. Kou, H.; Qing, Z.; Guo, H.; Zhang, R.; Ma, J. Effect of vitamin E supplementation in rheumatoid arthritis: A systematic review and meta-analysis. Eur. J. Clin. Nutr. 2023, 77, 166–172. [Google Scholar] [CrossRef]
  144. Turrubiates-Hernandez, F.J.; Marquez-Sandoval, Y.F.; Gonzalez-Estevez, G.; Reyes-Castillo, Z.; Munoz-Valle, J.F. The Relevance of Selenium Status in Rheumatoid Arthritis. Nutrients 2020, 12, 3007. [Google Scholar] [CrossRef] [PubMed]
  145. Walwadkar, S.D.; Suryakar, A.N.; Katkam, R.V.; Kumbar, K.M.; Ankush, R.D. Oxidative stress and calcium-phosphorus levels in Rheumatoid arthritis. Indian J. Clin. Biochem. IJCB 2006, 21, 134–137. [Google Scholar] [CrossRef] [PubMed]
  146. Hariharan, S.; Dharmaraj, S. Selenium and selenoproteins: It’s role in regulation of inflammation. Inflammopharmacology 2020, 28, 667–695. [Google Scholar] [CrossRef]
  147. Malhotra, S.; Welling, M.N.; Mantri, S.B.; Desai, K. In vitro and in vivo antioxidant, cytotoxic, and anti-chronic inflammatory arthritic effect of selenium nanoparticles. J. Biomed. Mater. Res. Part B Appl. Biomater. 2016, 104, 993–1003. [Google Scholar] [CrossRef]
  148. Cejka, D.; Hayer, S.; Niederreiter, B.; Sieghart, W.; Fuereder, T.; Zwerina, J.; Schett, G. Mammalian target of rapamycin signaling is crucial for joint destruction in experimental arthritis and is activated in osteoclasts from patients with rheumatoid arthritis. Arthritis Rheum. 2010, 62, 2294–2302. [Google Scholar] [CrossRef]
  149. Schonenberger, K.A.; Schupfer, A.C.; Gloy, V.L.; Hasler, P.; Stanga, Z.; Kaegi-Braun, N.; Reber, E. Effect of Anti-Inflammatory Diets on Pain in Rheumatoid Arthritis: A Systematic Review and Meta-Analysis. Nutrients 2021, 13, 4221. [Google Scholar] [CrossRef] [PubMed]
  150. Raad, T.; Griffin, A.; George, E.S.; Larkin, L.; Fraser, A.; Kennedy, N.; Tierney, A.C. Dietary Interventions with or without Omega-3 Supplementation for the Management of Rheumatoid Arthritis: A Systematic Review. Nutrients 2021, 13, 3506. [Google Scholar] [CrossRef]
  151. Mathieu, S.; Pereira, B.; Daien, C.; Tournadre, A.; Soubrier, M. Omega 3 Fatty Acids Intake Does Not Decrease the Risk of Rheumatoid Arthritis Occurrence: A Meta-Analysis. Comment on Tanski et al. The Relationship between Fatty Acids and the Development, Course and Treatment of Rheumatoid Arthritis. Nutrients 2022, 14, 1030. Nutrients 2023, 15, 539. [Google Scholar]
Figure 1. The induced factors for RA. The risk factors for RA are divided into genetic and non-genetic factors. HLA genes are strongest correlation with RA occurrence. Non-genetic factors include age, gender, infection, chemical exposure, basic disease, life style, and dietary pattern.
Figure 1. The induced factors for RA. The risk factors for RA are divided into genetic and non-genetic factors. HLA genes are strongest correlation with RA occurrence. Non-genetic factors include age, gender, infection, chemical exposure, basic disease, life style, and dietary pattern.
Ijms 26 02674 g001
Figure 2. Pathogenesis of RA: First, the self-tissue is mistakenly identified as foreign substance, which leads to the activation of the immune response and the persistence of inflammation. Second, many cytokines are secreted and released. The proliferation and migration of synovial cells release proangiogenic factors, promote angiogenesis, and lead to joint swelling. Finally, persistent inflammation leads to articular cartilage degeneration and bone destruction, and inflammatory factors promote the secretion of MMPs, causing destructive damage to cartilage.
Figure 2. Pathogenesis of RA: First, the self-tissue is mistakenly identified as foreign substance, which leads to the activation of the immune response and the persistence of inflammation. Second, many cytokines are secreted and released. The proliferation and migration of synovial cells release proangiogenic factors, promote angiogenesis, and lead to joint swelling. Finally, persistent inflammation leads to articular cartilage degeneration and bone destruction, and inflammatory factors promote the secretion of MMPs, causing destructive damage to cartilage.
Ijms 26 02674 g002
Figure 3. The potential harmful factors of a high-fat diet triggering RA: A long-term high-fat diet might result in endocrine dyscrasia, metabolic disorders, low-grade chronic inflammation of the whole body, reducing microbial diversity and the integrity of intestinal barrier, which contributes to inducing or aggravating RA.
Figure 3. The potential harmful factors of a high-fat diet triggering RA: A long-term high-fat diet might result in endocrine dyscrasia, metabolic disorders, low-grade chronic inflammation of the whole body, reducing microbial diversity and the integrity of intestinal barrier, which contributes to inducing or aggravating RA.
Ijms 26 02674 g003
Table 1. Diet of patients with RA and its effect on disease activity.
Table 1. Diet of patients with RA and its effect on disease activity.
Diet PatternsDietary TypesInfluencing MechanismReferences
Unbalanced diet patternsHigh-fat dietLong-term high-fat diet may lead to endocrine disorders, metabolic disorders, systemic low-grade chronic inflammation, reduce microbial diversity, and the integrity of the intestinal barrier, thus leading to the induction or aggravation of RA. [61,62]
High-sugar dietHigh glucose intake aggravates RA symptoms by increasing blood glucose and insulin levels, increasing inflammatory factors, accelerating joint degeneration, reducing bone mineral density, and leading to weight gain. [63,64]
High-salt dietIncreasing the intake of sodium chloride may decrease the number of T regulatory cells by activating pro-inflammatory macrophages and Th 17 cells and affecting the sodium sensitivity of Th 17 cells, thus increasing the risk of RA. [65,66]
Balanced diet patternsDietary fiber-rich dietDietary fiber may help alleviate the symptoms of rheumatoid arthritis by regulating inflammation, improving intestinal microbial community, controlling body weight, enhancing immune function, and maintaining intestinal barrier. [67,68]
Probiotics-rich dietProbiotics can significantly alleviate the occurrence and development of rheumatoid arthritis through immunomodulation, inhibiting inflammation, maintaining intestinal microbial balance, enhancing intestinal barrier function, and improving nutrient absorption. [69,70]
Vitamins-rich dietVitamins may play an active role in the management and treatment of rheumatoid arthritis through anti-inflammatory reaction, immunomodulation, antioxidation, and promoting bone health. [71,72]
Table 2. Study of the therapeutic effect of probiotics in RA.
Table 2. Study of the therapeutic effect of probiotics in RA.
Study Size and DurationProbiotic StrainResultsReferences
Forty-six patients with RA (8 weeks)Lactobacillus caseiDisease activity score was significantly decreased by the intervention, a statistically significant improvement in all pro-inflammatory biomarkers except for IL-1β.[69]
Sixty patients with RA (8 weeks)Lactobacillus acidophilus
Lactobacillus casei
Bifidobacterium bifidum
Taking probiotic supplements for 8 weeks among patients with RA had beneficial effects on DAS-28, insulin levels, HOMA-B, and hs-CRP levels.[133]
Male DBA/1J mouse model of RA (7 weeks)L. helveticus SBT2171The ability of L. helveticus SBT2171 to downregulate the abundance of immune cells and the subsequent production of CII-specific antibodies and IL-6, thereby suppressing the CIA symptoms.[134]
Male Wistar rat model of RA (4 weeks)Lactobacillus casei and Lactobacillus acidophilusTreatment with Lactobacillus casei and Lactobacillus acidophilus significantly downregulated pro-inflammatory cytokines and upregulated anti-inflammatory cytokines and significantly reduced the oxidative stress and arthritis score of synovial tissues.[135]
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Share and Cite

MDPI and ACS Style

Zhang, J.; Wang, X.; Fang, J.; Li, Y.; Yu, Y.; Wang, J.; Sun, B. Contributions of Dietary Patterns and Factors to Regulation of Rheumatoid Disease. Int. J. Mol. Sci. 2025, 26, 2674. https://doi.org/10.3390/ijms26062674

AMA Style

Zhang J, Wang X, Fang J, Li Y, Yu Y, Wang J, Sun B. Contributions of Dietary Patterns and Factors to Regulation of Rheumatoid Disease. International Journal of Molecular Sciences. 2025; 26(6):2674. https://doi.org/10.3390/ijms26062674

Chicago/Turabian Style

Zhang, Jingjie, Xueli Wang, Juan Fang, Yingying Li, Yonghui Yu, Jing Wang, and Baoguo Sun. 2025. "Contributions of Dietary Patterns and Factors to Regulation of Rheumatoid Disease" International Journal of Molecular Sciences 26, no. 6: 2674. https://doi.org/10.3390/ijms26062674

APA Style

Zhang, J., Wang, X., Fang, J., Li, Y., Yu, Y., Wang, J., & Sun, B. (2025). Contributions of Dietary Patterns and Factors to Regulation of Rheumatoid Disease. International Journal of Molecular Sciences, 26(6), 2674. https://doi.org/10.3390/ijms26062674

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop